Navigation Links
Biomerix Corporation and Gel Company Announce Strategic Distribution Agreement
Date:7/19/2011

FREMONT, Calif., July 19, 2011 /PRNewswire/ -- Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.

The Biomerix 3D Scaffold consists of a non-degradable, open-cell polycarbonate polyurethane, designed to mimic the nature and function of the extracellular matrix (ECM). Its unique three-dimensional microarchitecture embodies a network of interconnecting cells and pores constructed to support tissue ingrowth, allowing researchers to study cells in an environment that simulates the conditions of cells in the body.  The unique chemistry and macroporous structure of the Biomerix 3D Scaffold supports the growth of myriad cell types and delivers more predictive results compared to standard 2D cell culture systems.  The proprietary Biomerix Biomaterial, used to manufacture the Biomerix 3D Scaffold has been demonstrated to support optimal cell proliferation and superior cell viability in both in-vitro and in-vivo studies and has received seven US and international regulatory clearances for a variety of indications.

"We have already experienced interest in the Biomerix 3D Scaffold, and we are delighted to add this innovative technology to our portfolio of products," said Greg Richardson, President of the Gel Company. "The Biomerix 3D Scaffold is an excellent fit with our expertise in the life science research community."

"Biomerix is very pleased to have the Gel Company become one of our distribution partners.  Their reputation as a quality supplier, as well as their commitment to customer service, was appealing to Bi
'/>"/>

SOURCE Biomerix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Biomerix Awarded Two Device Licenses by Health Canada
2. Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh
3. Biomerix Ventral Hernia Repair Mesh Receives FDA 510(k) Clearance
4. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
5. QuantRx Biomedical Corporation Provides Corporate Update
6. American Scientific Resources and School Health Corporation to Supply The Disintegrator™ Needle Destruction Device to Texas School District
7. China Medicine Corporation to Restate Financial Statements for 2006 and 2007
8. CVS Caremark Corporation Announces Quarterly Dividend
9. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
10. Curaxis Pharmaceutical Corporation Announces Key Changes to Its Board of Directors and Management Team in Progression Toward Clinical Trials
11. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... developing and commercializing proven cancer therapies in new ... from its Phase I/II clinical trial of  VAL-083 ... the most common and deadly form of human ...
(Date:6/1/2015)... LONDON , June 1, 2015 ... carcinoma segment will drive growth , says   ... Cell Lung Cancer (NSCLC) treatment market will be driven primarily ... and squamous cell treatment settings, which either replace or combine ... GBI Research - Non-Small Cell Lung Cancer Market to ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global Power Wheelchair ... The Global Power Wheelchair Industry Report ... the current state of the power wheelchair industry. ... of the industry including definitions, classifications, applications and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3Global Power Wheelchair Industry Trends 2015-2020 2
... 2011 Alere Inc. (NYSE: ALR ), ... health at home through the merger of rapid diagnostics and health ... 31, 2010. Financial results for the fourth quarter ... the fourth quarter of 2010, compared to $546.2 million for the ...
... 2011 Cepheid (Nasdaq: CPHD ) today ... following investor conferences, and invited investors to participate via ... 1, 2011 at 8.30 a.m. Eastern TimeRBC Capital Markets, ... 11.00 a.m. Eastern TimeTo access the live webcasts for ...
Cached Medicine Technology:Alere Inc. Announces Fourth Quarter 2010 Results 2Alere Inc. Announces Fourth Quarter 2010 Results 3Alere Inc. Announces Fourth Quarter 2010 Results 4Alere Inc. Announces Fourth Quarter 2010 Results 5Alere Inc. Announces Fourth Quarter 2010 Results 6Alere Inc. Announces Fourth Quarter 2010 Results 7Alere Inc. Announces Fourth Quarter 2010 Results 8Alere Inc. Announces Fourth Quarter 2010 Results 9Alere Inc. Announces Fourth Quarter 2010 Results 10Alere Inc. Announces Fourth Quarter 2010 Results 11Alere Inc. Announces Fourth Quarter 2010 Results 12Alere Inc. Announces Fourth Quarter 2010 Results 13Alere Inc. Announces Fourth Quarter 2010 Results 14Alere Inc. Announces Fourth Quarter 2010 Results 15Alere Inc. Announces Fourth Quarter 2010 Results 16Alere Inc. Announces Fourth Quarter 2010 Results 17Alere Inc. Announces Fourth Quarter 2010 Results 18Alere Inc. Announces Fourth Quarter 2010 Results 19Cepheid to Webcast Upcoming Financial Presentations 2
(Date:6/2/2015)... 02, 2015 Join us for a new ... in Honor of Rhonda Martin , who overcame her brain ... dedicated their resources to raising awareness and funds for brain ... awareness in hopes that there will be one less case ... welcome and encouraged to join the 1st Anniversary Awareness ...
(Date:6/2/2015)... 2015 Pacifica Graduate Institute ... by current and former students to honor the memory ... from 2002 until his death in 2013. His students ... of feeling, as well as his passion for politics, ... an analyst, teacher, and writer were felt in his ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “We want men ... ultraviolet (UV) sun rays”, states Marta Phillips, owner of SunGrubbies.com, ... men’s sun hats and sun accessories that work well for ... not immediately evident. Sometimes sun damage can take up to ... neck are prime areas for skin cancer to occur. ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lynn Lester as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... Lester with this prestigious award,” said NAPW President Star ...
(Date:6/1/2015)... June 02, 2015 The National ... Ditmyer as a 2015-2016 inductee into the NAPW ... recognized with this prestigious distinction for leadership in academics. ... Local Chapters, NAPW is the nation’s leading networking organization ... Marcia with this important distinction,” said NAPW President Star ...
Breaking Medicine News(10 mins):Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... Researchers from Japan have recently demonstrated the first evidence ... ,Fungal secondary metabolites such as gliotoxin, an ... Aspergillus//, possess immunosuppressive activities and have been thought to ... humans. ,Mast cells play a key role ...
... who are prone to backaches, insomnia and eyesight problems ... treatment protocol for treating software professionals would be outlined ... Thrissur next month, said eminent ayurveda expert Neelakantan Mooss ... Thaikkattu Mooss Vaidyaratnam Oushadhasala, said detailed examinations had been ...
... from National Cancer Institute, US is to start testing their ... drug metabolize, enzyme kinetics and drug action mechanisms in dogs ... ,Dr. Chand Khanna, Veterinary Oncologist said, “It turns out that ... represented in dogs and the dogs will help us prioritize ...
... new research conducted in Helsinki, Finland, gluten-free diet ... adolescents with coeliac disease.,Coeliac disease in adolescents has ... and disruptive behavioural disorders, particularly in the phase ... 9 adolescents with coeliac disease, aged 12 to ...
... the first of its kind, French researchers report of ... with attention-deficit/hyperactivity disorder//. , The authors, ... present the case report of a 3-year-old child, who ... and sleep problems. ,According to the parents, ...
... is expected to get a major boost with the central ... in the interior regions//. ,Health Minister Anbumani ... northeastern states in Assam's main city of Guwahati with a ... adequate nursing staff. ,"We shall make it mandatory for ...
Cached Medicine News:Health News:Gluten-Free Diet May Alleviate Psychiatric Symptoms In Adolescents 2Health News:Iron Supplementation Aid In Relief From Attention-Deficit/Hyperactivity Disorder 2
... ACL 8000 is an easy-to-use, automated system ... array of assays for managing hemostatic disordersincluding ... S. Also offers reflex and rerun testing ... it's backed by our high-quality service to ...
... System is designed to provide excellent capture ... carotid stenting interventions. The ACCUNET is a ... utilizes rapid exchange technology so that the ... catheter manipulations. It is available in both ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: